Press Releases

Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants

Bacterial contamination of orthopaedic implants is a growing clinical challenge that burdens the healthcare system and can lead to dangerous, potentially fatal complications for patients. PARSIPPANY, N.J., April 8, 2024 /PRNewswire/ -- Onkos Surgical, an orthopaedic company founded to address the complex clinical challenges associated with bone loss due to tumor,...

Learn More

Onkos Surgical Announces Expanded Capability in Pediatric Musculoskeletal Oncology and Unveils New Manufacturing and Innovation Center

Company expands capabilities of its Precision Orthopaedics platform PARSIPPANY, N.J., July 19, 2023 /PRNewswire/ -- Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, announced its launch of the JTS Extendible Prosthesis, a novel growing implant designed for pediatric patients with bone cancer, and unveiled its new, state-of-the-art...

Learn More

Onkos Surgical Receives FDA 510(K) Clearance For 3D Printed, Patient-Specific Pelvic Reconstruction System

Company expands its portfolio of musculoskeletal oncology and complex orthopaedic solutions to include conditions of the pelvis PARSIPPANY, N.J., July 14, 2022 /PRNewswire/ — Onkos Surgical, a rapidly growing, leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced that it has received 510(k) clearance for its...

Learn More

Onkos Surgical Announces Definitive Agreement to Acquire the JTS Extendible Prosthesis

Company expands musculoskeletal oncology portfolio with device to treat pediatric bone cancer PARSIPPANY, N.J., June 13, 2022 /PRNewswire/ — Onkos Surgical, Inc., a rapidly growing, leading innovator of solutions for musculoskeletal oncology and complex orthopaedic conditions, announced today that it has entered into a definitive agreement with Stryker to acquire the...

Learn More

Onkos Surgical^® raises $15 million in series c funding

Funds will accelerate innovation, expand commercial presence, and drive manufacturing improvements in surgical solutions for musculoskeletal oncology and complex orthopaedicsPARSIPPANY, N.J., Sept. 1, 2021— Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced that it has raised $15 million in Series C funding...

Learn More

Onkos Surgical^® announces FDA 510(k) clearance of its BioGrip^® modular porous collars, a first-of-its-kind solution to help address implant loosening in orthopaedic oncology and complex revision surgery

The new offering, available as part of the ELEOS™ Limb Salvage System, is designed to help support bone ingrowth in musculoskeletal oncology and complex orthopaedic limb salvage cases with a novel 3D-printed porous designPARSIPPANY, N.J., June 22, 2021— Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex...

Learn More

Onkos Surgical^® celebrates patient experience week with focus on patient-centered innovation

PARSIPPANY, N.J., April 29, 2021 — In celebration of Patient Experience Week (April 26-30, 2021), Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced ongoing growth and adoption of its patient-centric innovations. These solutions are designed to help improve patient outcomes and experiences using...

Learn More

Onkos Surgical^® continues its innovation in musculoskeletal oncology and complex orthopaedic reconstruction with the launch of the ELEOS^™ Proximal Tibia with BioGrip^™ technology

PARSIPPANY, N.J., December 21, 2020 –  Onkos Surgical, Inc., an innovator in the field of musculoskeletal oncology and personalized orthopaedics, continues to deliver on its promise of commercializing innovative solutions with the launch of the new ELEOS Proximal Tibia with BioGrip technology. The product, used in complex tumor and orthopaedic...

Learn More

Business Update Regarding COVID-19

March 27, 2020 – We recognize that our customers, patients, caregivers, and partners have a great deal of information coming from all directions during this rapidly changing time. This memorandum is a brief update regarding what Onkos Surgical is doing to ensure business continuity. First, on behalf of everyone at Onkos,...

Learn More

Onkos Surgical^® to Launch New Personalized Surgery Platform with Disruptive Service Model for Joint Sparing Tumor Surgery

PARSIPPANY, N.J., September 26, 2019 – Onkos Surgical, Inc. announced today the launch of My3D™ Personalized Solutions powered by 3D Systems VSP® (Virtual Surgical Planning) Orthopaedics. The launch of this platform is the first of several products to be released under the companies’ previously announced collaboration to advance personalized solutions...

Learn More